End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 CNY | +9.96% |
|
+6.75% | +19.51% |
Jul. 09 | Shanghai Shyndec Pharmaceutical Obtains Drug Registration for Anti-Tumor Injection; Shares Jump 9% | MT |
Jun. 14 | Shyndec Pharma Unit Gets China Nod for Analgesic Ingredient | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.51% | 1.96B | |
+3.89% | 71.18B | |
+30.89% | 9.61B | |
+28.63% | 4.73B | |
-19.62% | 4.53B | |
+18.41% | 3.68B | |
-36.16% | 2.03B | |
-39.38% | 1.81B | |
-45.43% | 1.71B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 600420 Stock
- News Shanghai Shyndec Pharmaceutical Co., Ltd.
- Shyndec Pharmaceutical Unit's Cefprozil Tablets Passes Regulatory Evaluation